Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B7YT
|
||||
Former ID |
DAP000343
|
||||
Drug Name |
Scopolamine
|
||||
Synonyms |
Atrochin; Atroquin; Atroscine; Beldavrin; Euscopol; Hyosceine; Hyoscine; Hyosol; Hysco; Isoscopil; Kwells; Oscine; SEE; Scop; Scopamin; Scopolaminhydrobromid; Scopos; Sereen; Skopolamin; Tranaxine; Transcop; Triptone; Atroscine Hydrobromide; Epoxytropine tropate; Hydroscine hydrobromide; Hyocine F hydrobromide; Hyoscine bromide; Hyoscyine hydrobromide; Isopto Hyoscine; SCOPOLAMINE BROMIDE; Scopine tropate; Scopolamine Hyoscine; Scopolaminium bromide; Scopolammonium bromide; Transderm scop; Tropane alkaloid; MOLI001381; NCI61806; Borrachero (TN); Burundanga (TN); Hyoscine (TN); L-Hyoscine hydrobromide; L-Scopolamine; Scopoderm-TTS; Scopolamine (INN); Transderm scop (TN); Transderm-Scop; Transderm-V; Tropic acid, ester with scopine; Levo-duboisine (TN); Scopine (-)-tropate; Xy-, (-)-tropate (ester); Tropic acid, 9-methyl-3-oxa-9-azatricyclo(3.3.1.0(sup 2,4))non-7-yl ester; (+)-Hyoscine; (+)-Scopolamine; (-)-Hyoscine; (-)-Scopolamine; (-)-Scopolamine hydrobromide trihydrate; (1S,3S,5R,6R,7S)-6,7-epoxytropan-3-yl (2S)-3-hydroxy-2-phenylpropanoate; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epo; 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-, (-)-tropate (ester); 3-Oxa-9-azatricyclo(3.3.1.0(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); 3-Oxa-9-azatricyclo(3.3.1.O(sup 2,4))nonan-7-ol, 9-methyl-, tropate (ester); 6,7-Epoxytropine tropate; 6-beta,7-beta-Epoxy-3-alpha-tropanyl S-(-)-tropate; 6beta,7beta-Epoxy-1alpha,5alpha-tropan-3alpha-ol; 6beta,7beta-Epoxy-3alpha-tropanyl S-(-)-tropate; 9-methyl-3-oxa-9-azatricyclo[3.3.1.0~2,4~]non-7-yl tropate
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antispasmodics
|
||||
Company |
Norvatis Phamaceuticals Corporation
|
||||
Structure |
Download2D MOL |
||||
Formula |
C17H21NO4
|
||||
InChI |
InChI=1S/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11-,12-,13-,14+,15-,16+/m1/s1
|
||||
InChIKey |
STECJAGHUSJQJN-FWXGHANASA-N
|
||||
CAS Number |
CAS 51-34-3
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
ChEBI ID |
ChEBI:16794
|
||||
SuperDrug ATC ID |
A04AD01; N05CM05; S01FA02
|
||||
SuperDrug CAS ID |
cas=000051343
|
||||
Target and Pathway | |||||
Target(s) | Muscarinic acetylcholine receptor M2 | Target Info | Antagonist | [536730], [537137] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References | |||||
Ref 540261 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 330). | ||||
Ref 551436 | Drug Information of Calcidiol from nextbio research in illumina. 2015. | ||||
Ref 536730 | Midbrain acetylcholine and glutamate receptors modulate accumbal dopamine release. Neuroreport. 2008 Jun 11;19(9):991-5. | ||||
Ref 537137 | The amygdala modulates morphine-induced state-dependent memory retrieval via muscarinic acetylcholine receptors. Neuroscience. 2009 May 5;160(2):255-63. Epub 2009 Mar 9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.